-
Bufalin Workflow for TNBC Mechanism Studies
2026-09-02
Build a practical Bufalin workflow that connects viability and apoptosis readouts with STK33 target engagement, protein degradation, and organoid validation. The guide also covers formulation, assay controls, and troubleshooting for triple-negative breast cancer research and related oncology models.
-
gamma-Glu-Cys Workflows for Glutathione Research
2026-09-01
Use gamma-Glu-Cys as a defined substrate for glutathione synthetase enzyme assays, pathway studies, and controlled peptide workflows. Its value is greatest when researchers separate reproducible substrate testing from the complex medium effects revealed in Bacillus fermentation research.
-
Full-Length αvβ3 Integrin Structures by Cryo-EM
2026-09-01
A 2026 cryo-EM study resolves full-length human αvβ3 integrin in six apo and five ligand-bound conformations, including five previously uncharacterized states. The structures support a continuum model of integrin activation and clarify how CWHM-12 can stabilize distinct inhibited conformations, providing a framework for more selective inhibitor design.
-
Purmorphamine: An Assay-First Hedgehog Guide
2026-08-31
Purmorphamine is a Smoothened agonist for dissecting Hedgehog signaling in osteogenic, neural, and sensory models. This assay-first guide connects molecular pharmacology with the cross-species Smo evidence that determines how experiments should be designed and interpreted.
-
Tiamulin: Metabolism-Aware Assay Design
2026-08-31
Tiamulin (Thiamutilin) is more than a pleuromutilin antibiotic: its species-dependent metabolism directly affects residue testing, pharmacodynamic interpretation, and translational assay design. This evidence-led guide connects ribosomal pharmacology with practical veterinary and inflammation research workflows.
-
Z-LEHD-FMK: Caspase-9 Inhibition Workflows
2026-08-30
Z-LEHD-FMK helps separate mitochondria-mediated apoptosis from upstream stress and extrinsic death signaling in cell, cancer, and injury models. This practical guide covers assay design, pathway controls, formulation, and troubleshooting, with a focused application to SARS-CoV-2 ORF3a variant research.
-
KRas Transfer by Tunneling Nanotubes
2026-08-29
The reference study shows that tunneling nanotubes can transfer mutant KRas between tumor cells, converting previously different cells into a mechanically altered, more invasive population. By combining confocal fluorescence imaging, optical tweezers, and gene interference, the authors connect oncogenic protein transfer with reduced membrane tension, faster phospholipid flow, and tumor-cell migration.
-
Berberrubine chloride: Applied Research Workflows
2026-08-28
Berberrubine chloride supports target-focused cancer assays alongside metabolic, inflammatory, and urate studies. This workflow-centered guide covers DMSO preparation, concentration selection, orthogonal validation, and troubleshooting for more reproducible preclinical experiments.
-
BMS 599626 dihydrochloride: EGFR/HER2 Workflows
2026-08-28
BMS 599626 dihydrochloride enables mechanism-focused studies of EGFR and ErbB2 signaling, cancer cell proliferation inhibition, and pathway dependence in breast and lung cancer models. This practical guide pairs receptor-phosphorylation assays with viability, senescence, and xenograft-oriented workflows while clearly separating established evidence from assay-development suggestions.
-
Triptolide (PG490): Applied Research Workflows
2026-08-27
Build reproducible Triptolide workflows for transcriptional control, ovarian cancer invasion, immune-cell apoptosis, and inflammatory fibroblast assays. This guide also translates a 2025 acute pancreatitis study into practical AhR–HSF1 pathway experiments while separating validated evidence from exploratory use.
-
SP600125: Practical JNK Inhibitor Workflows
2026-08-26
SP600125 provides a reversible, ATP-competitive route to test how JNK signaling controls c-Jun phosphorylation, apoptosis, and inflammatory cytokines. This guide combines concentration planning, time-resolved readouts, Nrf2-focused assay design, and troubleshooting for cell-based and inflammation research.
-
Red Blood Cell Lysis Buffer in Bone Assays
2026-08-26
Discover how Red Blood Cell Lysis Buffer can improve pre-analytical control in bone and immunology assays without overstating mechanistic evidence. This guide connects selective erythrocyte removal with the RUNX2–AMPK findings reported in osteoblast research and provides a practical decision framework for flow cytometry, nucleic acid, and protein workflows.
-
Gemcitabine HCl in Pancreatic Cancer Research
2026-08-25
Gemcitabine HCl is a deoxycytidine analog used to study DNA replication inhibition, cytotoxicity, and tumor growth suppression. Its nanomolar activity in pancreatic cancer cell lines and compatibility with longitudinal MRI support integrated in vitro and preclinical research workflows.
-
AZD1390: ATM Kinase Inhibitor Workflow
2026-08-25
AZD1390 provides a precise way to test how ATM-dependent checkpoint signaling shapes radiation response, replication stress, and tumor-cell survival. This workflow connects low-nanomolar ATM inhibition with glioblastoma radiosensitization, lung cancer models, and emerging REV1–DHX36 G-quadruplex biology.
-
Amorolfine Hydrochloride in Yeast Stress Assays
2026-08-24
Amorolfine Hydrochloride is an antifungal reagent for dissecting fungal cell membrane disruption without overlooking ploidy-dependent surface stress. This article translates yeast genome-doubling research into a more rigorous framework for mechanism-focused fungal assays and resistance studies.